This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit

Home   About AST   Education   Meetings & Events   Public Policy   Contact Us   March 14, 2014



AST, transplant patient stakeholders claim victory, community applauds decision by CMS to abandon Medicare immunosuppressive drug coverage changes
The Hill
The Obama Administration informed top congressional leaders that it will not finalize any of the changes it had proposed to the Six Protected Classes policy in the Jan. 10 regulation, including the proposed removal of transplant immuno drugs from the protected class category. The AST submitted official comments opposing the rule to CMS, had its comments officially accepted and included in the congressional hearing record by the House E&C Health Subcommittee Chairman Pitts, R-Penn., was mentioned by name (AST) at the Congressional hearing as a key national organization opposed to the proposed rule, worked closely with members of the Senate and House to ask specific questions of CMS officials during the Capitol Hill hearing, and helped organize broader comments and direct lobbying with transplant stakeholder groups and other impacted parties, including the mental health community. Read some of the AST's communications to Congress and the Society's official comments opposing the CMS proposed rule.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

AST members: Continue referring your colleagues for a chance to win!
It's not too late for your transplant colleagues to join AST and receive discounted registration to the 2014 World Transplant Congress (WTC) in San Francisco. When you encourage your colleagues to join, you are helping them to grow both personally and professionally, and strengthening the transplant community by inviting new voices to be heard.

For each new member you recruit, your name will be entered to win one of three prizes, including an iPad and AST Bucks! Additionally, you will receive recognition for your efforts at the 2014 WTC, on the AST website, and in the AST eNews. To receive credit for your referrals, your colleagues must submit their applications by Monday, March 31, and pay their dues by May 1. Click here to learn more.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Webinars on 3/18, 3/20, 4/10, 4/22 - Free to AST Members
AST has several webinars taking place in March and April, all of which are available on demand after the live air date.
  • Hepatitis C Eradication: Liver Transplant Patients and Beyond Tues., 3/18, register online.
  • Fellows Webinar: The Future of Translational Research in Transplantation Thurs., 3/20, register online
  • Fellows Webinar: Drug Safety Thurs., 4/10, register online
  • Risk of Living Kidney Donation Tues., 4/22, register online

  • Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Understanding the new kidney allocation system
    In addition to AST's kidney allocation policy webinar available on demand free to AST members ($25 for non-members), UNOS offers several educational resources for understanding the new UNOS/OPTN kidney allocation system. The latest resource is an on demand webinar entitled "The New Kidney Allocation System: Basic Preparations." Visit either the UNOS Transplant Pro website or OPTN's website.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Become an AST Corporate Affiliate
    The AST thanks the following organizations for their participation in the 2014 Corporate Affiliates Program:
    Astellas Pharma US, Inc.
    Genentech, A Member of the Roche Group
    Novartis Pharmaceuticals Corporation
    Roche Diagnostics Corporation
    Veloxis Pharmaceuticals

    The AST Corporate Affiliates Program provides an exciting opportunity for companies to support the work of the AST and receive tangible benefits throughout the year. Benefits of participation include increased visibility, enhanced engagement opportunities, access to new marketing tools and up-to-date communication about the latest research and advocacy efforts in the field of transplantation. Click here for additional information.

    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Featured Advertisers

    UCLA Immunogenetics Center

    The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
    University of Utah - Multi-Organ Transplant Surgeon

    The University Of Utah Department Of Surgery is seeking applications for a faculty member to join the multi-organ transplant team at the assistant professor level. This is an opportunity to join an expanding program and a cohesive group of transplant surgeons focused on excellence. The candidate should be board certified in general surgery and have completed an ASTS approved transplantation surgery fellowship. Apply here
    2013 USIEC Excellence Award Winner

    OTTR is pleased to be recognized for Excellence in Software by USIEC and for receiving CIBMTR Certification. Please contact us at to see how we can help you.


    UNOS announces 2014-2015 Board of Directors election results
    Members of the national organ donation and transplantation community have elected 25 members to the OPTN/UNOS board of directors, including a new president, vice-president/president-elect, vice president of patient and donor affairs and secretary. The United Network for Organ Sharingserves as the Organ Procurement and Transplantation Network under federal contract.

    All board members are uncompensated volunteers and serve terms ranging from one to three years, depending on the office to which they are elected. Their terms of service begin on July 1.

    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    The role of procurement biopsies in acceptance decisions for kidneys received for transplant
    There is a shortage of kidneys for transplant, and many patients on the deceased donor kidney transplant waiting list would likely benefit from kidneys that are currently being discarded. In the United States, the most common reason given for discarding kidneys retrieved for transplant is procurement biopsy results. This study aimed to compare biopsy results from discarded kidneys with discard attributed to biopsy findings, with biopsy results from comparable kidneys that were successfully transplanted.

    Related article:
    The discard of deceased donor kidneys in the UK (Clinical Transplantation)

    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Study: Pneumonia in solid organ transplant recipients
    Transplant Infectious Disease (login required)
    Pneumonia frequently affects solid organ transplant (SOT) recipients, with high morbidity and mortality. However, the few studies on pneumonia in this population are mainly retrospective, single-center, and long-term studies, or include patients with only one type of SOT or a specific etiology. Authors performed a point prevalence study to investigate epidemiology, diagnosis, therapy, and outcome of pneumonia in an unselected SOT population.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Scientific retreat of international transplant skin cancer collaborative and skin cancer in organ transplant patients Europe
    American Journal of Transplantation (login required)
    The International Transplant Skin Cancer Collaborative (ITSCC) is an organization of more than 300 physicians and scientists focused on the study of dermatologic changes following solid organ transplantation. Transplant patients have a 100-fold increased risk of developing skin cancer. In October 2012, ITSCC and its European counterpart Skin Cancer in Organ Transplant Patients Europe held a joint biennial retreat in Essex, Mass., to discuss novel findings in the pathogenesis and management of skin cancer in solid organ transplant recipients. This meeting report is a summary of the novel findings discussed.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    Missed last week's issue? See which articles your colleagues read most.

        UNOS seeks applicants for Chief Medical Officer (TransplantPro)
    Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought (Transplant Infectious Disease)
    Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants (Transplantation)
    Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection (Transplantation)
    Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients (Transplant Infectious Disease)

    Don't be left behind. Click here to see what else you missed.

    UNOS receives funding to continue organ-labeling technology study
    The United Network for Organ Sharing said it has received additional federal funds from the U.S. Department of Health and Human Services for continued work on technology to electronically label and track donated organs for transplant. This technology, UNOS said, will enhance efficiency and patient safety by ensuring accuracy of key information on each package for transport.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    NIH opens research hospital to outside scientists
    National Institutes of Health
    Ten projects that will enable non-government researchers to conduct clinical research at the National Institutes of Health's Clinical Center in Bethesda, Md., were recently announced. Through these three-year, renewable awards of up to $500,000 per year, scientists from institutions across the United States will collaborate with government scientists in a highly specialized hospital setting. Applications for the next round of competitions for the awards are due on March 20.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

    AST eNews

    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Courtney Hodges, Content Editor, 972.402.2604   
    Contribute news

    This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

    Recent issues
    Feb. 7, 2014
    Jan. 31, 2014
    Jan. 24, 2014
    Jan. 17, 2014

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063